Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board

Thu, 15th Jul 2021 14:54

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday and not separately reported by Alliance News:

----------

Mitchells & Butlers PLC - Birmingham, England-based operator of pubs, bars and restaurants - Says non-executive directors Colin Rutherford and Imelda Walsh will step down from the board on Monday next week, while Ron Robson will depart as a non-executive director on July 31. Mitchells & Butlers had announced the three departures back in May as part of a reduction in the size of its board to nine members.

----------

Salt Lake Potash Ltd - Western Australia-focused organic sulphate of potash miner - Hires Stuart Fraser as chief financial officer. Fraser most recently was chief accounting officer at oil field services firm Weatherford International, having previously worked for peer Schlumberger.

----------

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Hires Michael Hayden as non-executive director, starting Thursday. Hayden is a Canadian who has founded five biotechnology companies and also served as president of Global R&D & chief scientific officer at Israel-based Teva Pharmaceuticals Industries Ltd from 2012 to 2017.

----------

Everyman Media Group PLC - operates fourth largest cinema chain in UK by number of venues - Hires Maggie Todd as independent non-executive director, effective immediately. Todd was vice president of Communications for Walt Disney Studios Motion Pictures in Europe for 12 years. She also worked at Twenty Century Fox.

----------

BMO Capital & Income Investment Trust PLC - investment trust with portfolio consisting mainly of FTSE All-Share companies - Senior Independent Director Clare Dobie retires, having served on the board since 2012. Tim Scholefield appointed senior independent director in her place.

----------

Troy Income & Growth Trust PLC - invests predominantly in UK equities - Hires Brigid Sutcliffe as non-executive director, starting August 1. Sutcliffe is a chartered accounting who worked in investment banking and as a management consultant. Jann Brown will retire from the board in January, having served for nine years, and Sutcliffe will take over as chair of the Audit Committee at that time.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2022 12:01

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:

Read more
22 Apr 2022 09:21

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

Read more
20 Apr 2022 17:11

LONDON MARKET CLOSE: Stocks up as G20 finance heads meet; Netflix down

(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on the tech-heavy Nasdaq index.

Read more
20 Apr 2022 12:11

LONDON MARKET MIDDAY: Europe pushes higher as Netflix shockwave wanes

(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US earnings season.

Read more
20 Apr 2022 10:00

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause.

Read more
20 Apr 2022 09:10

Oxford Biomedica reports year of solid growth

(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although its outlook was somewhat less rosy amid a pause in vaccine manufacturing.

Read more
13 Apr 2022 16:05

UK earnings, trading statements calendar - next 7 days

Thursday 14 April 
Ashmore Group PLCTrading Statement
Dunelm Group PLCTrading Statement
Hays PLCTrading Statement
Mediclinic International PLCTrading Statement
Ninety One PLC and LtdTrading Statement
Norcros PLCTrading Statement
Friday 15 April 
no events scheduled 
Monday 18 April 
no events scheduled 
Tuesday 19 April  
JTC PLCFull Year Results
Kainos Group PLCTrading Statement
Rio Tinto PLCQ1 Production Results
Wednesday 20 April  
Bunzl PLCTrading Statement
Carr's Group PLCHalf Year Results
Centamin PLCTrading Statement
Hunting PLCTrading Statement
IntegraFin Holdings PLCTrading Statement
John Wood Group PLCFull Year Results
Oxford Biomedica PLCFull Year Results
Petra Diamonds LtdTrading Statement
Quilter PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Feb 2022 09:37

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

Read more
1 Feb 2022 08:51

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Read more
1 Feb 2022 07:40

Oxford Biomedica's Parkinson's licensee pulls out

(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK company.

Read more
28 Jan 2022 19:17

UPDATE: Oxford BioMedica raises GBP80 million via placing

UPDATE: Oxford BioMedica raises GBP80 million via placing

Read more
28 Jan 2022 16:59

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

Read more
28 Jan 2022 16:19

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

Read more
28 Jan 2022 12:13

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

Read more
28 Jan 2022 10:27

Oxford BioMedica to acquire 80% ownership of new US virus business

Oxford BioMedica to acquire 80% ownership of new US virus business

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.